DCM
ANIK icon

Dupont Capital Management’s Anika Therapeutics ANIK Stock Holding History

Dupont Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,024
Closed -$348K – 1347
2020
Q1 		$348K Sell
12,024
-4,431
-27% -$179K 0.01% 800
2019
Q4 		$853K Hold
16,455
– – 0.02% 625
2019
Q3 		$903K Buy
16,455
+5,481
+50% +$281K 0.02% 557
2019
Q2 		$446K Hold
10,974
– – 0.01% 838
2019
Q1 		$332K Hold
10,974
– – 0.01% 917
2018
Q4 		$369K Buy
+10,974
New +$396K 0.01% 831
2017
Q3 		– Sell
-20,764
Closed -$1.02M – 940
2017
Q2 		$1.02M Sell
20,764
-7,522
-27% -$346K 0.02% 524
2017
Q1 		$1.23M Sell
28,286
-643
-2% -$30.7K 0.03% 467
2016
Q4 		$1.42M Buy
28,929
+2,220
+8% +$103K 0.03% 405
2016
Q3 		$1.28M Sell
26,709
-16,308
-38% -$806K 0.03% 402
2016
Q2 		$2.31M Hold
43,017
– – 0.05% 276
2016
Q1 		$1.92M Sell
43,017
-6,748
-14% -$274K 0.04% 331
2015
Q4 		$1.9M Hold
49,765
– – 0.05% 351
2015
Q3 		$1.58M Hold
49,765
– – 0.04% 375
2015
Q2 		$1.64M Hold
49,765
– – 0.04% 371
2015
Q1 		$2.05M Hold
49,765
– – 0.04% 363
2014
Q4 		$2.03M Sell
49,765
-340
-0.7% -$13.3K 0.04% 341
2014
Q3 		$1.84M Hold
50,105
– – 0.03% 345
2014
Q2 		$2.32M Sell
50,105
-1,590
-3% -$70.7K 0.04% 342
2014
Q1 		$2.13M Sell
51,695
-11,818
-19% -$439K 0.03% 362
2013
Q4 		$2.42M Sell
63,513
-9,837
-13% -$303K 0.04% 304
2013
Q3 		$1.76M Sell
73,350
-18,165
-20% -$408K 0.03% 400
2013
Q2 		$1.56M Buy
+91,515
New +$1.32M 0.03% 419

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dupont Capital Management's ANIK Position: Q2 2020 in Review

Dupont Capital Management sold out of Anika Therapeutics (ANIK) in Q2 2020, closing a stake of 12,024 shares — an estimated $348K sold.

Dupont Capital Management first reported a position in ANIK in Q2 2013 and held it in 23 quarters. The position peaked at $2.42M in Q4 2013. 158 funds tracked by Wall St. Rank hold ANIK as of Q2 2020.

  • Dupont Capital Management reported no remaining Anika Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Dupont Capital Management sold 12,024 Anika Therapeutics shares in Q2 2020, an estimated $348K.
  • Dupont Capital Management first reported a position in Anika Therapeutics in Q2 2013 and held it in 23 quarters.
  • Dupont Capital Management's Anika Therapeutics position peaked at $2.42M in Q4 2013.
  • 158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2020.

Based on Dupont Capital Management's 13F filing for Q2 2020, filed 24 Jul 2020.